AquaBounty Technologies, Inc.
General ticker "AQB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.5M (TTM average)
AquaBounty Technologies, Inc. follows the US Stock Market performance with the rate: 36.3%.
Estimated limits based on current volatility of 4.6%: low 0.96$, high 1.06$
Factors to consider:
- Total employees count: 104 (+4.0%) as of 2023
- Top business risk factors: Customer concentration, Operational and conduct risks, Cybersecurity threats, Geopolitical risks, Currency fluctuations
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.43$, 1.41$]
- 2025-12-31 to 2026-12-31 estimated range: [0.25$, 0.85$]
Financial Metrics affecting the AQB estimates:
- Positive: with PPE of -0.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -567.73 <= 0.33
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 309.74 > -0.66
- Positive: -8.75 < Industry operating profit margin (median), % of -1.95
- Positive: Industry inventory ratio change (median), % of -1.09 <= -0.15
Short-term AQB quotes
Long-term AQB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3.14MM | $0.00MM | $0.00MM |
| Operating Expenses | $25.46MM | $13.67MM | $9.52MM |
| Operating Income | $-22.32MM | $-13.67MM | $-9.52MM |
| Non-Operating Income | $0.17MM | $-0.17MM | $-104.23MM |
| Interest Expense | $0.29MM | $0.30MM | $2.29MM |
| R&D Expense | $0.90MM | $0.51MM | $0.20MM |
| Income(Loss) | $-22.16MM | $-13.84MM | $-113.75MM |
| Profit(Loss)* | $-22.16MM | $-27.56MM | $-149.19MM |
| Stockholders Equity | $191.92MM | $165.02MM | $15.84MM |
| Inventory | $2.33MM | $0.00MM | $0.00MM |
| Assets | $213.84MM | $187.55MM | $34.06MM |
| Operating Cash Flow | $-21.01MM | $-24.24MM | $-13.86MM |
| Capital expenditure | $67.48MM | $68.89MM | $2.93MM |
| Investing Cash Flow | $34.35MM | $-68.89MM | $7.56MM |
| Financing Cash Flow | $-0.16MM | $-0.31MM | $-2.66MM |
| Earnings Per Share** | $-6.24 | $-7.17 | $-38.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.